AstraZeneca, Torrent Settle Time-Release Seroquel IP Row
As part of the consent judgment, Torrent admitted AstraZeneca’s patent on the anti-depressant is enforceable and valid, and agreed not to produce a generic version of Seroquel XR until November 2016.
Representatives for the parties did not immediately respond to requests for comment Friday.
AstraZeneca filed suit...
To view the full article, register now.